357 related articles for article (PubMed ID: 17993954)
21. In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel.
Mazzeffi M; Szlam F; Jakubowski JA; Tanaka KA; Sugidachi A; Levy JH
Thromb Res; 2013 Jul; 132(1):106-11. PubMed ID: 23664633
[TBL] [Abstract][Full Text] [Related]
22. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
Sørensen B; Asvaldsdottir HS; Gudmundsdottir BR; Onundarson PT
Thromb Res; 2009 Dec; 124(6):695-700. PubMed ID: 19733387
[TBL] [Abstract][Full Text] [Related]
23. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
Takeshita S; Ogawa S; Nakayama Y; Mukai N; Nakajima Y; Mizobe T; Sawa T; Tanaka KA
Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649
[TBL] [Abstract][Full Text] [Related]
24. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time.
Kheirabadi BS; Crissey JM; Deguzman R; Holcomb JB
J Trauma; 2007 Jun; 62(6):1352-9; discussion 1359-61. PubMed ID: 17563647
[TBL] [Abstract][Full Text] [Related]
25. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
Perzborn E; Heitmeier S; Laux V; Buchmüller A
Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses.
Leclere M; Lavoie JP; Dunn M; Bédard C
Vet Clin Pathol; 2009 Dec; 38(4):462-6. PubMed ID: 19548973
[TBL] [Abstract][Full Text] [Related]
27. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).
Viuff D; Lauritzen B; Pusateri AE; Andersen S; Rojkjaer R; Johansson PI
Br J Anaesth; 2008 Sep; 101(3):324-31. PubMed ID: 18565966
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography.
Koestenberger M; Gallistl S; Muntean W; Ferstl U; Kutschera J; Cvirn G
Blood Coagul Fibrinolysis; 2005 Nov; 16(8):613-7. PubMed ID: 16269937
[TBL] [Abstract][Full Text] [Related]
29. Multimodal assessment of non-specific hemostatic agents for apixaban reversal.
Martin AC; Gouin-Thibault I; Siguret V; Mordohay A; Samama CM; Gaussem P; Le Bonniec B; Godier A
J Thromb Haemost; 2015 Mar; 13(3):426-36. PubMed ID: 25630710
[TBL] [Abstract][Full Text] [Related]
30. Activity of recombinant factor VIIa under different conditions in vitro: effect of temperature, pH, and haemodilution.
Bladbjerg EM; Jespersen J
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):369-74. PubMed ID: 18600084
[TBL] [Abstract][Full Text] [Related]
31. A thromboelastometric evaluation of the effects of hypothermia on the coagulation system.
Rundgren M; Engström M
Anesth Analg; 2008 Nov; 107(5):1465-8. PubMed ID: 18931200
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.
Pusateri AE; Park MS
Crit Care; 2005; 9 Suppl 5(Suppl 5):S15-24. PubMed ID: 16221315
[TBL] [Abstract][Full Text] [Related]
33. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
Sørensen B; Ingerslev J
J Thromb Haemost; 2004 Jan; 2(1):102-10. PubMed ID: 14717973
[TBL] [Abstract][Full Text] [Related]
34. The in vitro effect of recombinant factor VIIa on coated platelet formation and clot dynamics of stored platelet concentrates.
Svendsen MS; Kristensen AT; Bochsen L; Salado-Jimena JA; Johansson PI
Transfusion; 2009 Oct; 49(10):2186-94. PubMed ID: 19527478
[TBL] [Abstract][Full Text] [Related]
35. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.
Lindahl TL; Wallstedt M; Gustafsson KM; Persson E; Hillarp A
Thromb Res; 2015 Mar; 135(3):544-7. PubMed ID: 25596769
[TBL] [Abstract][Full Text] [Related]
36. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
[TBL] [Abstract][Full Text] [Related]
37. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
38. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):547-53. PubMed ID: 17762530
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
Godier A; Miclot A; Le Bonniec B; Durand M; Fischer AM; Emmerich J; Marchand-Leroux C; Lecompte T; Samama CM
Anesthesiology; 2012 Jan; 116(1):94-102. PubMed ID: 22042412
[TBL] [Abstract][Full Text] [Related]
40. Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation.
Whelihan MF; Kiankhooy A; Brummel-Ziedins KE
J Crit Care; 2014 Feb; 29(1):24-30. PubMed ID: 24331944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
